About: Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH)
Creator	Coleman, Catherine Abdullah, Farah Armenian, Saro Bebel, Samantha Echevarria, Meagan Emmons, Karen Geller, Alan Iukuridze, Aleksi Lindenfeld, Lanie Marghoob, Ashfaq Modi, Badri Nakamura, Ryotaro Oeffinger, Kevin
source	Medline; PMC
abstract	BACKGROUND: Hematopoietic cell transplantation (HCT) is a curative option for a growing number of patients with hematologic diseases and malignancies. However, HCT-related factors, such as total body irradiation used for conditioning, graft-versus-host disease, and prolonged exposure to immunosuppressive therapy, result in very high risk for melanoma and non-melanoma skin cancer (NMSC). In fact, skin cancer is the most common subsequent neoplasm in HCT survivors, tending to develop at a time when survivors’ follow-up care has largely transitioned to the primary care setting. The goal of this study is to increase skin cancer screening rates among HCT survivors through patient-directed activation alone or in combination with physician-directed activation. The proposed intervention will identify facilitators of and barriers to risk-based screening in this population and help reduce the burden of cancer-related morbidity after HCT. METHODS/DESIGN: 720 HCT survivors will be enrolled in this 12-month randomized controlled trial. This study uses a comparative effectiveness design comparing (1) patient activation and education (PAE, N = 360) including text messaging and print materials to encourage and motivate skin examinations; (2) PAE plus primary care physician activation (PAE + Phys, N = 360) adding print materials for the physician on the HCT survivors’ increased risk of skin cancer and importance of conducting a full-body skin exam. Patients on the PAE + Phys arm will be further randomized 1:1 to the teledermoscopy (PAE + Phys+TD) adding physician receipt of a portable dermatoscope to upload images of suspect lesions for review by the study dermatologist and an online course with descriptions of dermoscopic images for skin cancers. DISCUSSION: When completed, this study will provide much-needed information regarding strategies to improve skin cancer detection in other high-risk (e.g. radiation-exposed) cancer survivor populations, and to facilitate screening and management of other late effects (e.g. cardiovascular, endocrine) in HCT survivors. TRIAL REGISTRATION: ClinicalTrials.gov, NCT04358276. Registered 24 April 2020.
has issue date	2020-08-03(xsd:dateTime)
bibo:doi	10.1186/s12885-020-07232-2
bibo:pmid	32746799
has license	cc-by
sha1sum (hex)	5e57cada1e8e3e7a2e4531cadfe5b81a9595b4e0
schema:url	https://doi.org/10.1186/s12885-020-07232-2
resource representing a document's title	Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH)
has PubMed Central identifier	PMC7397711
has PubMed identifier	32746799
schema:publication	BMC Cancer
resource representing a document's body	covid:5e57cada1e8e3e7a2e4531cadfe5b81a9595b4e0#body_text
is schema:about of	named entity 'skin cancer' named entity 'screening' named entity 'fact' named entity 'activation' named entity 'EXPOSURE TO' named entity 'SKIN CANCER SCREENING' named entity 'DIRECTED' named entity 'RESULT' named entity 'HCT' named entity 'ACTIVATION' named entity 'combination' named entity 'patients' named entity 'number' named entity 'The goal' named entity 'survivors' named entity 'follow-up' named entity 'total body irradiation' named entity 'HCT' named entity 'HCT' named entity 'hematologic diseases' named entity 'HCT' named entity 'skin cancer' named entity 'hematopoietic cell' named entity 'endocrine' named entity 'follow-up' named entity 'Medicare' named entity 'long-term' named entity 'dermatologists' named entity 'Medicare' named entity 'Type I error' named entity 'text messaging' named entity 'dermatologist' named entity 'invasive surgical procedures' named entity 'preventive health' named entity 'informs' named entity 'dermatoscope' named entity 'dermatologist' named entity 'health care' named entity 'skin cancer' named entity 'allogeneic' named entity 'chronic health conditions' named entity 'skin cancer' named entity 'PCP' named entity 'immunosuppression' named entity 'cancer center' named entity 'general population' named entity 'skin cancer' named entity 'PAE' named entity 'skin cancer' named entity 'chronic diseases' named entity 'SSE' named entity 'SCC' named entity 'skin cancer' named entity 'hypothesis testing' named entity 'sensitivity analysis' named entity 'health promotion' named entity 'cancer screening' named entity 'HCT' named entity 'physical activity' named entity 'skin cancer' named entity 'dermatology' named entity 'PCP' named entity 'e-learning' named entity 'PAE' named entity 'melanoma' named entity 'Type I error' named entity 'autologous' named entity 'GVHD' named entity 'magnifying lens'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software